ENDRA Life Sciences Inc.

NASDAQ: NDRA · Real-Time Price · USD
4.48
0.04 (0.90%)
At close: Aug 15, 2025, 9:50 AM

ENDRA Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 211.6K n/a n/a n/a 428.41K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 105.8K n/a 50.12K 55.68K 61.25K 70.45K 72.71K 71.04K 67.77K 58.59K 55.68K 52.22K 53.67K 61.51K 60.37K 48.87K
Gross Profit
n/a 105.8K n/a -50.12K -55.68K 367.16K -70.45K -72.71K -71.04K -67.77K -58.59K -55.68K -52.22K -53.67K -61.51K -60.37K -48.87K
Operating Income
n/a -4.3M -1.51M -2.23M -2.78M -1.46M -3.13M -2.99M -2.94M -3.31M -3.42M -3.57M -2.86M -3.07M -2.65M -3.2M -2.58M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-1.04M -4.15M -2.35M -2.23M -2.78M -1.46M -3.1M -2.56M -2.94M -3.29M -3.44M -3.59M -2.86M -3.1M -2.66M -3.2M -2.27M
Net Income
-1.04M -4.15M -2.35M -2.23M -2.78M -1.46M -3.1M -2.56M -2.95M -3.27M -3.46M -3.61M -2,858.2B -3.1M -2.66M -3.2M -2.27M
Selling & General & Admin
940.6K 3.66M 714.57K 1.51M 1.74M 878.43K 1.5M 1.59M 1.55M 1.65M 1.59M 1.72M 1.64M 1.65M 1.48M 1.46M 1.43M
Research & Development
528.68K 637.96K 794.44K 716.37K 1.04M 579.35K 1.63M 1.4M 1.39M 1.66M 1.83M 1.85M 1.21M 1.42M 1.17M 1.74M 1.14M
Other Expenses
n/a n/a n/a n/a 4.84K -1.76K 28.23K 437.43K -3.42K 23.79K -23.01K -19.37K -2.93K -33.09K -7.51K 1.09K -2.04K
Operating Expenses
1.47M 4.3M 1.51M 2.23M 2.72M 1.4M 3.13M 2.99M 2.94M 3.31M 3.42M 3.57M 2.86M 3.07M 2.65M 3.2M 2.58M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a 3.42K n/a 23.01K 19.37K 2,858.2B n/a n/a n/a n/a
Selling & Marketing Expenses
68.99K 86.27K 83.16K 162.95K 238.66K 147.83K 243.33K 247.77K 181.62K 326.77K 420.44K 342.04K 339.9K 382.11K 275.56K 256.76K 160.94K
Cost & Expenses
n/a 4.46M 1.51M 2.23M 2.78M 1.46M 3.13M 2.99M 2.94M 3.31M 3.42M 3.57M 2.86M 3.07M 2.65M 3.2M 2.58M
Income Tax Expense
n/a n/a n/a n/a 4.00 3.00 n/a n/a 3.42K -23.79K 23.01K 19.37K 2,858.2B n/a -7.51K 1.09K n/a
Shares Outstanding (Basic)
557.58K 536.91K 1.12M 1.71M 1.71M 1.71M 1.71M 1.71M 1.93M 1.93M 1.93M 1.93M 2.15M 2.1M 2.1M 2.08M 1.89M
Shares Outstanding (Diluted)
557.58K 536.91K 1.12M 1.71M 1.71M 1.71M 1.71M 1.71M 1.93M 1.93M 1.93M 1.93M 2.15M 2.1M 2.1M 2.08M 1.89M
EPS (Basic)
-1.86 -7.73 -2.1 -1.31 -1.63 -0.85 -1.82 -1.5 -1.53 -1.69 -1.79 -1.87 -1.33M -1.48 -1.27 -1.54 -1.2
EPS (Diluted)
-1.86 -7.73 -2.1 -1.31 -1.63 -0.85 -1.82 -1.5 -1.53 -1.69 -1.79 -1.87 -1.33M -1.48 -1.27 -1.54 -1.2
EBITDA
n/a -4.25M -1.5M -2.18M -2.72M -1.4M -3.03M -2.96M -2.87M -3.22M -3.38M -3.54M -2.81M -3.05M -2.6M -3.14M -2.54M
EBIT
n/a -4.15M -1.51M -2.23M -2.78M -1.46M -3.13M -2.99M -2.94M -3.31M -3.42M -3.57M -2.86M -3.1M -2.65M -3.2M -2.58M
Depreciation & Amortization
n/a 46.36K 54.01K 50.12K 55.68K 61.25K 70.45K 72.71K 71.04K 67.77K 58.59K 55.68K 52.22K 53.67K 61.51K 60.37K 48.87K